Louise Curcio
Senior Director of Marketing, Lumos Diagnostics
Louise Curcio brings 20+ years of brand marketing leadership across medical devices and consumer products, with a track record of building categories and scaling brands. She led brand strategy at CooperVision that doubled the myopia management business and drove Yu-Gi-Oh from $5M to $200M at Upper Deck. Louise speaks on augmented brand strategy—how AI accelerates strategic preparation while human judgment drives the decisions that matter.
Building the Commercialization Engine After FDA Clearance: A Playbook for the AI-Augmented Brand Manager
Louise Curcio
Senior Director of Marketing, Lumos Diagnostics
Session Overview
FDA clearance is the beginning of commercialization. In this session, you’ll discover how AI is helping brand managers build stronger commercialization engines by improving market insight, sharpening positioning, and accelerating launch execution. Drawing on a real-world case study from Lumos Diagnostics, you’ll see practical examples of AI in action at different stages of the commercialization journey.
Key Takeaways
- The three capabilities every AI-augmented brand manager should develop.
- A practical framework for building a commercialization engine after FDA clearance.
- AI workflows you can apply directly to your next launch.
Panel Discussion: Modernizing MedTech Commercialization: From Insight to Evidence to Adoption
Panelists
Debbie Donovan, Materna Medical
Anusha Vishwanathan, Ex-Medtronic, Abbott Vascular, and Aerin Medical, Inc
Ana Crespo, Marketing Maven
Moderator
Louise Curcio, Lumos Diagnostics
Session Overview
Bringing a medical device to market requires far more than a great product or a great marketing campaign. Successful commercialization requires teams to connect customer insight, product strategy, clinical and economic evidence, digital engagement, commercial execution, and emerging technology into a strategy that ultimately drives adoption.
This panel brings together leaders with perspectives spanning product management, commercial operations, market access, sales strategy, digital enablement, data, and AI transformation to explore how MedTech organizations can better connect these disciplines across the commercialization journey. Panelists will share practical lessons on understanding the market, building and activating the right evidence, using digital channels and data to engage customers, operationalizing commercial strategy, measuring what matters, and applying emerging technologies such as AI where they can create meaningful value.